Levofloxacin Bluefish 500 mg film-coated tablets Airija - anglų - HPRA (Health Products Regulatory Authority)

levofloxacin bluefish 500 mg film-coated tablets

bluefish pharmaceuticals ab - levofloxacin - film-coated tablet - 500 milligram(s) - fluoroquinolones; levofloxacin

Tavanic 5 mg/ml solution for infusion Airija - anglų - HPRA (Health Products Regulatory Authority)

tavanic 5 mg/ml solution for infusion

sanofi-aventis ireland limited t/a sanofi - levofloxacin - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin

Tavanic 500 mg film-coated tablets Airija - anglų - HPRA (Health Products Regulatory Authority)

tavanic 500 mg film-coated tablets

sanofi-aventis ireland limited t/a sanofi - levofloxacin - film-coated tablet - 500 milligram(s) - fluoroquinolones; levofloxacin

Tavanic 250 mg film-coated tablets Airija - anglų - HPRA (Health Products Regulatory Authority)

tavanic 250 mg film-coated tablets

sanofi-aventis ireland limited t/a sanofi - levofloxacin - film-coated tablet - 250 milligram(s) - fluoroquinolones; levofloxacin

Levofloxacin Krka 250 mg film-coated tablets Airija - anglų - HPRA (Health Products Regulatory Authority)

levofloxacin krka 250 mg film-coated tablets

krka, d.d., novo mesto - levofloxacin hemihydrate - film-coated tablet - 250 milligram(s) - fluoroquinolones; levofloxacin - pharmacotherapeutic group: quinolone antibacterials, fluoroquinolones, - it is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1): - acute bacterial sinusitis. - acute exacerbations of chronic bronchitis. - community-acquired pneumonia. - complicated skin and soft tissue infections

Levofloxacin Krka 500 mg film-coated tablets Airija - anglų - HPRA (Health Products Regulatory Authority)

levofloxacin krka 500 mg film-coated tablets

krka, d.d., novo mesto - levofloxacin hemihydrate - film-coated tablet - 500 milligram(s) - fluoroquinolones; levofloxacin - quinolone antibacterials, fluoroquinolones - it is indicated in adults for the treatment of the following infections (see sections 4.4 and 5.1): - acute bacterial sinusitis. - acute exacerbations of chronic bronchitis. - community-acquired pneumonia. - complicated skin and soft tissue infections

Levofloxacin 5mg/ml solution for infusion, freeflex bags Airija - anglų - HPRA (Health Products Regulatory Authority)

levofloxacin 5mg/ml solution for infusion, freeflex bags

fresenius kabi deutschland gmbh - levofloxacin - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin

Levofloxacin 5mg/ml Solution for infusion, glass bottle Airija - anglų - HPRA (Health Products Regulatory Authority)

levofloxacin 5mg/ml solution for infusion, glass bottle

baxter holding b.v. - levofloxacin hemihydrate - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin

Levofloxacin 5mg/ml solution for infusion, LDPE bottles Airija - anglų - HPRA (Health Products Regulatory Authority)

levofloxacin 5mg/ml solution for infusion, ldpe bottles

fresenius kabi deutschland gmbh - levofloxacin - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin

Levofloxacin 5mg/ml Solution for infusion, Non PVC bag Airija - anglų - HPRA (Health Products Regulatory Authority)

levofloxacin 5mg/ml solution for infusion, non pvc bag

baxter holding b.v. - levofloxacin hemihydrate - solution for infusion - 5 milligram(s)/millilitre - fluoroquinolones; levofloxacin